Announced
Completed
Financials
Sources
Tags
China
Venture Capital
drug research
Friendly
Single Bidder
Pharmaceuticals
Cross Border
Completed
Private
Acquisition
drug manufacturing
Private Equity
Minority
Synopsis
Private equity firms The Carlyle Group and Warburg Pincus led a $123m series D funding round in Abbisko Therapeutics, a biopharmaceutical and drug development company. OrbiMed, Lake Bleu Capital, Janchor Partners, Sage Partners, Greater Bay Area Homeland, Lilly Asia Ventures, Temasek Holdings, Qiming Venture Partners, Hankang Capital and CICC Capital also joined the round. The proceeds will be used to accelerate the progress of its clinical programs and further expand its preclinical pipeline.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.